The Association between Serum Gamma- Glutamyltransferase within Normal Levels and Metabolic Syndrome in Office Workers: A 4-Year Follow-up Study

다국어 초록 (Multilingual Abstract)

Background: Serum gamma-glutamyltransferase (GGT) has been suggested as a predictor for development of the metabolic syndrome in non-Korean population, but studies in Korean population are scarce. Therefore, we examined the association between serum GGT levels and the incidence of the metabolic syndrome in Korean male office workers.
Methods: The study population consisted of 32,692 office workers who underwent health checkups in both 2005 and 2009.
A total of 17,583 with elevated GGT levels, the presence of metabolic syndrome, medication history at baseline, and female office workers were excluded. Finally, 15,109 subjects were included in the final analysis. We measured serum GGT levels and individual metabolic components.
Results: As a quartile of serum GGT increased, 4-year follow-up incidence of the metabolic syndrome increased. After adjustment for age, alcohol drinking status and smoking status in 2005, logistic regression analysis showed that the odds ratios (95%confidence interval) for incident metabolic syndrome in 2009 compared to the lowest quartile and upper quartiles were 1.00(reference), 1.57 (1.24-2.00), 2.73 (2.17-3.43), 3.78 (3.02-4.74), and statistically significant (P < 0.001), respectively.
Conclusion: These results showed that the higher serum GGT predicted the future development of metabolic syndrome. In Korean male office workers without the metabolic syndrome, the serum GGT levels despite normal levels were associated with an increased risk of incident metabolic syndrome.

참고문헌 (Reference)

1 오신웅, "혈청 감마지티피 농도에 따른 대사증후군 발생 위험" 대한가정의학회 29 (29): 838-843, 2008

2 Kang YH, "The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults" 77 : 306-313, 2007

3 The Ministry of Health and W, "The Third Korea National Health & Nutrition Examination Survey (KNHANES III), 2005" The Ministry of Health and Welfare 2006

4 World Health Organization Western Pacific Region, "The Asia-Pacific perspective: redefining obesity and its treatment" Health Communications Australia Pty Ltd. 2000

5 Nakanishi N, "Serum gammaglutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men" 27 : 1427-1432, 2004

6 Jousilahti P, "Serum gammaglutamyl transferase, self-reported alcohol drinking, and the risk of stroke" 31 : 1851-1855, 2000

7 이병완, "Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors" BLACKWELL PUBLISHING 22 : 1134-1140, 200509

8 Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome" 50 : 1844-1850, 2001

9 Lee DH, "Is serum gamma glutamyltransferase a marker of oxidative stress?" 38 : 535-539, 2004

10 Ceriello A, "Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited" 24 : 816-823, 2004

11 Wannamethee G, "Gammaglutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes" 142 : 699-708, 1995

12 Lee DH, "Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study" 49 : 1358-1366, 2003

13 Ruttmann E, "Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults" 112 : 2130-2137, 2005

14 Andre P, "Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort" 30 : 2355-2361, 2007

15 Rantala AO, "Gamma-glutamyl transpeptidase and the metabolic syndrome" 248 : 230-238, 2000

16 Kazemi-Shirazi L, "Gamma glutamyltransferase and longterm survival: is it just the liver?" 53 : 940-946, 2007

17 Lee DS, "Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study" 27 : 127-133, 2007

18 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)" 285 : 2486-2497, 2001

19 Pintus F, "Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group" 12 : 71-76, 1996

20 Pradhan AD, "C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus" 286 : 327-334, 2001

21 Freeman DJ, "C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study" 51 : 1596-1600, 2002